Literature DB >> 35471112

Quantitative MRI Characterization of the Extremely Preterm Brain at Adolescence: Atypical versus Neurotypical Developmental Pathways.

Ryan McNaughton1, Chris Pieper1, Osamu Sakai1, Julie V Rollins1, Xin Zhang1, David N Kennedy1, Jean A Frazier1, Laurie Douglass1, Timothy Heeren1, Rebecca C Fry1, T Michael O'Shea1, Karl K Kuban1, Hernán Jara1.   

Abstract

Background Extremely preterm (EP) birth is associated with higher risks of perinatal white matter (WM) injury, potentially causing abnormal neurologic and neurocognitive outcomes. MRI biomarkers distinguishing individuals with and without neurologic disorder guide research on EP birth antecedents, clinical correlates, and prognoses. Purpose To compare multiparametric quantitative MRI (qMRI) parameters of EP-born adolescents with autism spectrum disorder, cerebral palsy, epilepsy, or cognitive impairment (ie, atypically developing) with those without (ie, neurotypically developing), characterizing sex-stratified brain development. Materials and Methods This prospective multicenter study included individuals aged 14-16 years born EP (Extremely Low Gestational Age Newborns-Environmental Influences on Child Health Outcomes Study, or ELGAN-ECHO). Participants underwent 3.0-T MRI evaluation from 2017 to 2019. qMRI outcomes were compared for atypically versus neurotypically developing adolescents and for girls versus boys. Sex-stratified multiple regression models were used to examine associations between spatial entropy density (SEd) and T1, T2, and cerebrospinal fluid (CSF)-normalized proton density (nPD), and between CSF volume and T2. Interaction terms modeled differences in slopes between atypically versus neurotypically developing adolescents. Results A total of 368 adolescents were classified as 116 atypically (66 boys) and 252 neurotypically developing (125 boys) participants. Atypically versus neurotypically developing girls had lower nPD (mean, 557 10 × percent unit [pu] ± 46 [SD] vs 573 10 × pu ± 43; P = .04), while atypically versus neurotypically developing boys had longer T1 (814 msec ± 57 vs 789 msec ± 82; P = .01). Atypically developing girls versus boys had lower nPD and shorter T2 (eg, in WM, 557 10 × pu ± 46 vs 580 10 × pu ± 39 for nPD [P = .006] and 86 msec ± 3 vs 88 msec ± 4 for T2 [P = .003]). Atypically versus neurotypically developing boys had a more moderate negative association between T1 and SEd (slope, -32.0 msec per kB/cm3 [95% CI: -49.8, -14.2] vs -62.3 msec per kB/cm3 [95% CI: -79.7, -45.0]; P = .03). Conclusion Atypically developing participants showed sexual dimorphisms in the cerebrospinal fluid-normalized proton density (nPD) and T2 of both white matter (WM) and gray matter. Atypically versus neurotypically developing girls had lower WM nPD, while atypically versus neurotypically developing boys had longer WM T1 and more moderate T1 associations with microstructural organization in WM. © RSNA, 2022 Online supplemental material is available for this article.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35471112      PMCID: PMC9340244          DOI: 10.1148/radiol.210385

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   29.146


  35 in total

1.  Conference summary: a celebration of a century of neonatal care.

Authors:  Jonathan M Whitfield; Beverly A Peters; Craig Shoemaker
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-07

2.  Functional changes in CSF volume estimated using measurement of water T2 relaxation.

Authors:  S K Piechnik; J Evans; L H Bary; R G Wise; P Jezzard
Journal:  Magn Reson Med       Date:  2009-03       Impact factor: 4.668

Review 3.  More than a drainage fluid: the role of CSF in signaling in the brain and other effects on brain tissue.

Authors:  Sebastian Illes
Journal:  Handb Clin Neurol       Date:  2017

Review 4.  A review of diffusion MRI of typical white matter development from early childhood to young adulthood.

Authors:  Catherine Lebel; Sarah Treit; Christian Beaulieu
Journal:  NMR Biomed       Date:  2017-09-08       Impact factor: 4.044

Review 5.  White matter injury in the preterm infant: pathology and mechanisms.

Authors:  Stephen A Back
Journal:  Acta Neuropathol       Date:  2017-05-22       Impact factor: 17.088

Review 6.  Quantifying brain microstructure with diffusion MRI: Theory and parameter estimation.

Authors:  Dmitry S Novikov; Els Fieremans; Sune N Jespersen; Valerij G Kiselev
Journal:  NMR Biomed       Date:  2018-10-15       Impact factor: 4.044

7.  Prevalence and associated features of autism spectrum disorder in extremely low gestational age newborns at age 10 years.

Authors:  Robert M Joseph; Thomas M O'Shea; Elizabeth N Allred; Tim Heeren; Deborah Hirtz; Nigel Paneth; Alan Leviton; Karl C K Kuban
Journal:  Autism Res       Date:  2016-05-25       Impact factor: 5.216

8.  Evolution of T1 Relaxation, ADC, and Fractional Anisotropy during Early Brain Maturation: A Serial Imaging Study on Preterm Infants.

Authors:  J Schneider; T Kober; M Bickle Graz; R Meuli; P S Hüppi; P Hagmann; A C Truttmann
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-22       Impact factor: 3.825

9.  Altered myelin maturation in four year old children born very preterm.

Authors:  Marlee M Vandewouw; Julia M Young; Manohar M Shroff; Margot J Taylor; John G Sled
Journal:  Neuroimage Clin       Date:  2018-12-11       Impact factor: 4.881

10.  White matter microstructure and cognitive outcomes in relation to neonatal inflammation in 6-year-old children born preterm.

Authors:  Sarah E Dubner; Cory K Dodson; Virginia A Marchman; Michal Ben-Shachar; Heidi M Feldman; Katherine E Travis
Journal:  Neuroimage Clin       Date:  2019-04-22       Impact factor: 4.881

View more
  1 in total

Review 1.  Primary Multiparametric Quantitative Brain MRI: State-of-the-Art Relaxometric and Proton Density Mapping Techniques.

Authors:  Hernán Jara; Osamu Sakai; Ezequiel Farrher; Ana-Maria Oros-Peusquens; N Jon Shah; David C Alsop; Kathryn E Keenan
Journal:  Radiology       Date:  2022-08-30       Impact factor: 29.146

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.